AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 21- 52-wk high
- $70.98
- 52-wk low
- $49.26
- Prev close
- $62.07
- Mkt cap
- $13.10B
- P/E
- 188.0x
- Fwd P/E
- 14.0x
Smart money
Earnings
Earnings came in 13.9% above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $776.1M | $874.6M | $766.2M | $989.7M |
| Cost of what it sold | $140.1M | $295.1M | $195.0M | $202.8M |
| Gross profit | $636.0M | $579.5M | $571.2M | $786.9M |
| What it spent | ||||
| Research and development | $409.5M | $192.4M | $178.8M | $207.0M |
| Sales and admin | $137.1M | $802.1M | $133.4M | $253.3M |
| Other operating costs | $136.2M | -$494.4M | $129.4M | $215.7M |
| Total operating expenses | $682.7M | $500.1M | $441.6M | $676.0M |
| What was left | ||||
| Operating profit | -$46.7M | $79.4M | $129.6M | $110.9M |
| Interest on debt | $2.6M | $2.8M | $15.0M | $63.3M |
| Profit before tax | -$26.3M | -$27.2M | $141.2M | $61.4M |
| Tax | $4.4M | $19.4M | $35.7M | $16.6M |
| Net profit | -$30.7M | -$46.6M | $105.5M | $44.8M |
| EBITDA | -$5.3M | -$3.9M | $172.6M | $222.3M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
35 articles · 7 days
Coverage is bullish
Tone of tracked coverage
BioMarin initiated an outperform at BMO as Voxzogo erosion overstated
NeutralAug 19H.C. Wainwright cuts BioMarin stock price target on acquisition costs
Leans bearishAug 19GSA Capital Partners LLP Invests $944,000 in BioMarin Pharmaceutical Inc. $BMRN
Leans bullishAug 19
